Masahiro Nomoto Selected Research

Masahiro Nomoto Research Topics

Disease

44	Parkinson Disease (Parkinson's Disease) 03/2022 - 12/2003
8	Dyskinesias (Dyskinesia) 05/2022 - 07/2007
6	Pain (Aches) 10/2021 - 07/2004
3	Movement Disorders (Movement Disorder) 05/2022 - 09/2004
3	Sleepiness 07/2018 - 01/2014
3	Parkinsonian Disorders (Parkinsonism) 09/2011 - 09/2004
2	Hypokinesia (Bradykinesia) 03/2022 - 10/2021
2	Tremor (Tremors) 03/2022 - 02/2018
2	Dementia (Dementias) 01/2021 - 07/2019
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2019 - 12/2018
2	Neoplasms (Cancer) 02/2016 - 02/2009
1	Schizophrenia (Dementia Praecox) 05/2022
1	Tardive Dyskinesia 05/2022
1	Dystonia (Limb Dystonia) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2020
1	Stomach Ulcer (Gastric Ulcer) 07/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2019
1	Drug-Related Side Effects and Adverse Reactions 07/2019
1	Multiple Sclerosis 06/2019
1	Encephalitis (Encephalitis, Rasmussen) 06/2019
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 03/2019
1	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 12/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 04/2018
1	Onychomycosis (Tinea Unguium) 01/2018
1	Crystalluria 12/2017
1	Gout 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2017
1	Urolithiasis 12/2017
1	Fatigue 05/2017
1	Thrombophilia 09/2015
1	Stroke (Strokes) 09/2015
1	Partial Epilepsies (Epilepsy, Partial) 01/2014
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2013
1	Nervous System Diseases (Neurological Disorders) 01/2013

Drug/Important Bio-Agent (IBA)

26	Levodopa (L Dopa)FDA LinkGeneric 10/2021 - 12/2003
6	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 07/2004
5	safinamideIBA 03/2022 - 01/2020
5	rotigotine FDA Link 02/2018 - 09/2013
5	Pharmaceutical PreparationsIBA 12/2017 - 09/2004
3	opicaponeIBA 01/2021 - 01/2021
3	ropinirole (Requip)FDA LinkGeneric 01/2021 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2005
3	Monoamine Oxidase (MAO)IBA 01/2020 - 11/2005
3	Selegiline (E250)FDA LinkGeneric 07/2019 - 01/2010
3	Mitochondrial DNA (mtDNA)IBA 03/2019 - 12/2018
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2018 - 08/2007
3	Amantadine (Aman)FDA LinkGeneric 12/2010 - 11/2005
2	Cholinergic Antagonists (Anticholinergics)IBA 05/2022 - 11/2005
2	TabletsIBA 01/2021 - 01/2020
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2020
2	Zonisamide (Zonegran)FDA LinkGeneric 07/2019 - 04/2011
2	Apomorphine FDA Link 11/2015 - 08/2014
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2014 - 07/2007
2	CannabinoidsIBA 07/2007 - 09/2004
2	Opioid Analgesics (Opioids)IBA 07/2007 - 09/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2022
1	Antipsychotic Agents (Antipsychotics)IBA 05/2022
1	Tetrabenazine (Nitoman)FDA Link 05/2022
1	Dopamine AntagonistsIBA 05/2022
1	Reserpine (Serpasil)FDA Link 05/2022
1	istradefyllineIBA 10/2021
1	Vesicular Transport Adaptor ProteinsIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 12/2020
1	Guanfacine (Tenex)FDA LinkGeneric 12/2020
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 12/2020
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 07/2020
1	Sodium Channels (Sodium Channel)IBA 01/2020
1	Sodium Channel BlockersIBA 01/2020
1	AntibodiesIBA 06/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	ProdrugsIBA 12/2018
1	Carbidopa (Lodosyn)FDA LinkGeneric 12/2018
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2018
1	Modafinil (Provigil)FDA Link 04/2018
1	Ciclopirox (Loprox)FDA LinkGeneric 01/2018
1	amorolfineIBA 01/2018
1	2- (3,5- dimethyl- 1H- pyrazol- 1- yl)- 5- methylphenolIBA 01/2018
1	efinaconazoleIBA 01/2018
1	Antifungal AgentsIBA 01/2018
1	tavaboroleIBA 01/2018
1	Inosine FDA Link 12/2017
1	Uric Acid (Urate)IBA 12/2017
1	Trastuzumab (Herceptin)FDA Link 02/2016
1	CholesterolIBA 09/2015
1	fibrin fragment D (D-dimer)IBA 09/2015
1	AlbuminsIBA 09/2015
1	Fibrinogen (Factor I)FDA Link 09/2015
1	Pregabalin (Lyrica)FDA Link 01/2014
1	Nicotine FDA Link 03/2013

Therapy/Procedure

12	Therapeutics 05/2022 - 03/2007
2	Drug Therapy (Chemotherapy) 01/2017 - 08/2007
1	Deep Brain Stimulation 05/2022
1	Digestive System Surgical Procedures 01/2020
1	Tobacco Use Cessation Devices 03/2013